Citations 1
P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
Eyre, Toby A. , Shah, N. N., Dreyling, Martin, Wang, Y., Gandhi, M., Chay, C., Sharman, Jeff P. , Andorsky, David , Yin, Ming , Balbas, Minna, Kherani, Jennifer , Wang, M. L., Gouill, Steven Le , Vandenberghe, Elisabeth , Jurczak, Wojciech , Wang, Yucai , Cheah, Chan Y. , Yin, M.
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 990-991
